Alaunos Therapeutics (TCRT) Change in Account Payables (2016 - 2025)
Historic Change in Account Payables for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to $34000.0.
- Alaunos Therapeutics' Change in Account Payables fell 6304.35% to $34000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $386000.0, marking a year-over-year increase of 14595.24%. This contributed to the annual value of -$100000.0 for FY2024, which is 8706.34% up from last year.
- Latest data reveals that Alaunos Therapeutics reported Change in Account Payables of $34000.0 as of Q3 2025, which was down 6304.35% from -$22000.0 recorded in Q2 2025.
- Alaunos Therapeutics' Change in Account Payables' 5-year high stood at $2.7 million during Q1 2021, with a 5-year trough of -$2.6 million in Q2 2021.
- For the 5-year period, Alaunos Therapeutics' Change in Account Payables averaged around -$15631.6, with its median value being -$22000.0 (2025).
- In the last 5 years, Alaunos Therapeutics' Change in Account Payables crashed by 48367.35% in 2021 and then surged by 175789.47% in 2025.
- Alaunos Therapeutics' Change in Account Payables (Quarter) stood at -$229000.0 in 2021, then tumbled by 179.91% to -$641000.0 in 2022, then decreased by 6.24% to -$681000.0 in 2023, then skyrocketed by 108.66% to $59000.0 in 2024, then plummeted by 42.37% to $34000.0 in 2025.
- Its last three reported values are $34000.0 in Q3 2025, -$22000.0 for Q2 2025, and $315000.0 during Q1 2025.